Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Weighted Average)
Others
Ratios

Mainz Biomed (MYNZ) EBIT (2022 - 2023)

Historic EBIT for Mainz Biomed (MYNZ) over the last 2 years, with Q4 2023 value amounting to -$6.6 million.

  • Mainz Biomed's EBIT rose 2143.98% to -$6.6 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$26.6 million, marking a year-over-year decrease of 75.87%. This contributed to the annual value of -$18.7 million for FY2024, which is 2983.44% up from last year.
  • Mainz Biomed's EBIT amounted to -$6.6 million in Q4 2023, which was up 2143.98% from -$5.6 million recorded in Q3 2023.
  • In the past 5 years, Mainz Biomed's EBIT registered a high of -$5.5 million during Q3 2022, and its lowest value of -$8.4 million during Q4 2022.